Suchergebnisse - "Langer, Jakob"

PubPharm (9)

1

A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice : The JAGUAR Study

enthalten in: Advances in therapy | 2021

von Kaneko, S. | da Rocha Fernandes, J. | Yamamoto, Y. | +2

2

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan : A Short-Term Cost-Effectiveness Analysis

enthalten in: Advances in therapy | 2020

von Igarashi, A. | Hunt, B. | Wilkinson, L. | +2

3

Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US

enthalten in: Journal of medical economics | 2018

von Dempsey, M. | Mocarski, M. | Langer, J. | +1

4

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Mocarski, M. | Yeaw, J. | Divino, V. | +4

5

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

ErratumIn: Adv Ther. 2017 Jun;34(6):1500-1501. - PMID 28523624

6

Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States

enthalten in: Journal of medical economics | 2016

von Durden, E. | Lenhart, G. | Lopez-Gonzalez, L. | +2

7

Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide : a retrospective cohort study

enthalten in: Advances in therapy | 2015

von Buysman, E. | Liu, F. | Hammer, M. | +1

8

Clinical effectiveness of liraglutide across body mass index in patients with type 2 diabetes in the United States : a retrospective cohort study

enthalten in: Advances in therapy | 2014

von Chitnis, A. | Ganz, M. | Benjamin, N. | +2

9

Real-world cost-effectiveness : lower cost of treating patients to glycemic goal with liraglutide versus exenatide

enthalten in: Advances in therapy | 2014

von DeKoven, M. | Lee, W. | Bouchard, J. | +2

1
[1]